- VolitionRx Limited to Present at Jefferies Global Healthcare Conference
- VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
- VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
- Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
- VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
- VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
- Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
- Volition appoints Dr Andrew Retter as Chief Medical Officer
More ▼
Key statistics
On Saturday, VolitionRX Ltd (VNRX:ASQ) closed at 0.6799, 23.62% above the 52 week low of 0.55 set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.694 |
---|---|
High | 0.70 |
Low | 0.666 |
Bid | 0.66 |
Offer | 0.70 |
Previous close | 0.69 |
Average volume | 83.80k |
---|---|
Shares outstanding | 82.82m |
Free float | 63.11m |
P/E (TTM) | -- |
Market cap | 59.63m USD |
EPS (TTM) | -0.4603 USD |
Data delayed at least 15 minutes, as of Jun 08 2024.
More ▼